Buscar
Mostrando documentos 1-10 de 30
Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis
Background
Hydroxychloroquine or chloroquine with or without azithromycin have been widely promoted to treat COVID-19 following early in vitro antiviral effects against SARS-CoV-2
Objective
The aim of this systematic ...
Never Give Up: Lesson learned from a severe COVID-19 patient
COVID-19 pandemic is causing major health consequences
in affected persons needing hospital admission. Since the
first epidemic outbreak in China we have learned that
several factors including older age, comorbidities ...
Can pioglitazone be potentially useful therapeutically in treating patients with COVID-19?
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a pandemic disease (COVID-19) that has spread globally causing more than 30,000
deaths. Despite the immense and ongoing global effort, no efficacious ...
4 Cases of Aortic Thrombosis in Patients With COVID-19
Since the outbreak of the COVID-19 pandemic, increasing evidence suggests that infected patients present a high incidence
of thrombotic complications. This report describes 4 cases of aortic thrombosis in patients admitted ...
Extent of prior lung irradiation and mortality in COVID-19 patients with a cancer history
Purpose: There have been nearly 200,000 deaths worldwide so far from coronavirus disease 2019 (COVID-19), which is caused by a
coronavirus called SARS-CoV-2. Cancer history appears to be a poor prognostic factor for ...
High aspartate aminotransferase to alanine aminotransferase ratio on admission as risk factor for poor prognosis in COVID‑19 patients
This study aimed to analyze aspartate aminotransferase (AST) to alanine aminotransferase (ALT) ratio
in COVID-19 patients. After exclusion, 567 inpatients were included in this study and separated into
two groups according ...
Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial
No effective drug treatments are available for coronavirus disease 2019 (COVID-19). Host-directed therapies targeting the underlying
aberrant immune responses leading to pulmonary tissue damage, death, or long-term ...
A validated, real-time prediction model for favorable outcomes in hospitalized COVID-19 patients
The COVID-19 pandemic has challenged front-line clinical decision-making, leading to numerous published prognostic tools. However,
few models have been prospectively validated and none report implementation in practice. ...
Developing health policies in patients presenting with SARS-CoV-2: consider tuberculosis
The global pandemic of COVID-19 has led to a
prominent public health response, with many countries
introducing highly proactive measures for screening
and identifying severe acute respiratory syndrome
coronavirus 2 ...
Kidney Infarction in Patients With COVID-19
Coronavirus disease 2019 (COVID-19) is a contagious life-threatening infection caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Recent findings indicate an
increased risk for acute kidney injury ...